324 related articles for article (PubMed ID: 26459254)
21. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
22. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.
Shuai Y; Li C; Zhou X
Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719
[TBL] [Abstract][Full Text] [Related]
23. Metformin may improve the prognosis of patients with pancreatic cancer.
Zhang JW; Sun Q
Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
[TBL] [Abstract][Full Text] [Related]
24. Conventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis.
Wu Y; Liu HB; Shi XF; Song Y
PLoS One; 2014; 9(6):e99577. PubMed ID: 24924771
[TBL] [Abstract][Full Text] [Related]
25. Metformin use improves the survival of diabetic combined small-cell lung cancer patients.
Kong F; Gao F; Liu H; Chen L; Zheng R; Yu J; Li X; Liu G; Jia Y
Tumour Biol; 2015 Sep; 36(10):8101-6. PubMed ID: 25983003
[TBL] [Abstract][Full Text] [Related]
26. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
[TBL] [Abstract][Full Text] [Related]
27. Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis.
Yao L; Liu M; Huang Y; Wu K; Huang X; Zhao Y; He W; Zhang R
Dis Markers; 2019; 2019():6230162. PubMed ID: 30881522
[TBL] [Abstract][Full Text] [Related]
28. Metformin Has Positive Therapeutic Effects in Colon Cancer and Lung Cancer.
Henderson D; Frieson D; Zuber J; Solomon SS
Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
[TBL] [Abstract][Full Text] [Related]
30. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
[No Abstract] [Full Text] [Related]
31. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.
Yin M; Zhou J; Gorak EJ; Quddus F
Oncologist; 2013; 18(12):1248-55. PubMed ID: 24258613
[TBL] [Abstract][Full Text] [Related]
32. The effect of metformin on mortality following cancer among patients with diabetes.
Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of metformin for non-small cell lung cancer patients with diabetes.
Xu T; Li D; He Y; Zhang F; Qiao M; Chen Y
World J Surg Oncol; 2018 Mar; 16(1):60. PubMed ID: 29558957
[TBL] [Abstract][Full Text] [Related]
34. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
[TBL] [Abstract][Full Text] [Related]
35. Metformin use and lung cancer risk in patients with diabetes.
Sakoda LC; Ferrara A; Achacoso NS; Peng T; Ehrlich SF; Quesenberry CP; Habel LA
Cancer Prev Res (Phila); 2015 Feb; 8(2):174-9. PubMed ID: 25644512
[TBL] [Abstract][Full Text] [Related]
36. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
He XK; Su TT; Si JM; Sun LM
Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
[TBL] [Abstract][Full Text] [Related]
37. Metformin and the risk of neurodegenerative diseases in patients with diabetes: A meta-analysis of population-based cohort studies.
Zhang Y; Zhang Y; Shi X; Han J; Lin B; Peng W; Mei Z; Lin Y
Diabet Med; 2022 Jun; 39(6):e14821. PubMed ID: 35213749
[TBL] [Abstract][Full Text] [Related]
38. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis.
Zhang ZJ; Bi Y; Li S; Zhang Q; Zhao G; Guo Y; Song Q
Am J Epidemiol; 2014 Jul; 180(1):11-4. PubMed ID: 24920786
[TBL] [Abstract][Full Text] [Related]
39. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.
Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F
Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557
[TBL] [Abstract][Full Text] [Related]
40. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
